Malignant pleural mesothelioma (MPM): analysis of consecutive 100 patients

被引：0
|
作者：
El-Kasem, FA [1 ]
Gaafar, R [1 ]
Abdelrahman, AM [1 ]
Abdelbaki, H [1 ]
Hassan, N [1 ]
机构：
[1] Cairo Univ, Natl Canc Inst, Cairo, Egypt
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [41] Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)
    Yoneda, Kazue
    Tanaka, Fumihiro
    Kondo, Nobuyuki
    Hashimoto, Masaki
    Takuwa, Teruhisa
    Matsumoto, Seiji
    Okumura, Yoshitomo
    Tsubota, Noriaki
    Sato, Ayuko
    Tsujimura, Tohru
    Kuribayashi, Kozo
    Fukuoka, Kazuya
    Tabata, Chiharu
    Nakano, Takashi
    Hasegawa, Seiki
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S472 - S480
  • [42] Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)
    Kazue Yoneda
    Fumihiro Tanaka
    Nobuyuki Kondo
    Masaki Hashimoto
    Teruhisa Takuwa
    Seiji Matsumoto
    Yoshitomo Okumura
    Noriaki Tsubota
    Ayuko Sato
    Tohru Tsujimura
    Kozo Kuribayashi
    Kazuya Fukuoka
    Chiharu Tabata
    Takashi Nakano
    Seiki Hasegawa
    Annals of Surgical Oncology, 2014, 21 : 472 - 480
  • [43] RETROSPECTIVE REVIEW OF PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Cedres Perez, S. M.
    Torrejon, D.
    Martinez, P.
    Nunez, I.
    Mulet-Margalef, N.
    Rodriguez-Freixinos, V.
    Montero, M. A.
    Felip, E.
    LUNG CANCER, 2011, 71 : S48 - S48
  • [44] DNA methylation profile predicts survival of patients with resected malignant pleural mesothelioma (MPM)
    Ceresoli, G. L.
    Destro, A.
    Baryshnikova, E.
    Garassino, I.
    Zucali, P. A.
    Morenghi, E.
    Testori, A.
    Alloisio, M.
    Roncalli, M.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Botta, M.
    Aitini, E.
    Spigno, F.
    Degiovanni, D.
    Alabiso, O.
    Serra, M.
    Muzio, A.
    Carbone, R.
    Buosi, R.
    Galbusera, V.
    Piccolini, E.
    Giaretto, L.
    Rebella, L.
    Mencoboni, M.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 370 - 373
  • [46] Old and new prognostic factors in a series of 910 patients with malignant pleural mesothelioma (MPM)
    Linton, Anthony
    Pavlakis, Nick
    O'Connell, Rachel
    Soeberg, Matthew
    Kao, Steven Chuan-Hao
    Clarke, Stephen John
    Vardy, Janette L.
    Van Zandwijk, Nico
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] SMO mutation identifies a subgroup of malignant pleural mesothelioma (MPM) patients with a worse prognosis
    Ganzinelli, Monica
    Proto, Claudia
    Signorelli, Diego
    Botta, Laura
    Pasello, Giulia
    Tiseo, Marcello
    Trama, Annalisa
    Gatta, Gemma
    Busico, Adele
    Fabbri, Alessandra
    Zaffaroni, Nadia
    Pelosi, Giuseppe
    Pastorino, Ugo
    De Braud, Filippo
    Vitali, Milena
    Garassino, Marina C.
    CANCER RESEARCH, 2016, 76
  • [48] Vinorelbine (V) in pemetrexed-pretreated patients (PTS) with malignant pleural mesothelioma (MPM)
    Lorenzi, E.
    Gianoncelli, L.
    Zucali, P.
    Ceresoli, G.
    De Vincenzo, F.
    Simonelli, M.
    Ripa, C.
    Giordano, L.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] VINORELBINE (V) IN PEMETREXED-PRETREATED PATIENTS (PTS) WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    De Vincenzo, F.
    Lorenzi, E.
    Zucali, P. A.
    Simonelli, M.
    Gianoncelli, L.
    Ceresoli, G. L.
    Ripa, C.
    Giordano, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 161 - 161
  • [50] Malignant Pleural Mesothelioma (MPM): New predictors of survival and an analysis of the impact of current treatment
    Flores, R
    Zakowski, M
    Venkatramen, E
    Krug, L
    Rosenzweig, K
    Dycoco, J
    Yeoh, C
    Lee, C
    Bains, M
    Rusch, V
    LUNG CANCER, 2005, 49 : S28 - S28
12345